SGLT2 inhibitors lowers risk of atrial fibrillation: Review Medha Baranwal4 Jan 2021 6:00 PM ISTUSA: People treated with SGLT2 inhibitors are at significantly lower risk of developing atrial fibrillation (AF), suggests a recent review in the...
Combination Therapy in Hypertension with Diabetes: Preferential Consideration for CCB and ARBs Dr. Pramila Kalra4 Jan 2021 12:45 PM ISTThe last edition of the International Diabetes Federation (IDF) Atlas offered projections that continue to put India at the second slot in the...
Bariatric surgery increases risk of low blood sugar in obese diabetics: Study Medha Baranwal3 Jan 2021 8:23 PM ISTUK: Obese patients with diabetes undergoing gastric bypass surgery are at increased risk of developing low blood sugar (hypoglycemia) post-surgery,...
Eli Lilly gets CDSCO Committee nod for marketing authorization for Insulin Lispro MD Bureau1 Jan 2021 6:17 PM ISTNew Delhi: In a major rejoice to Eli Lilly and Company (India) Pvt. Ltd., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Semaglutide reduces major adverse CV event risk in Diabetics with raised triglycerides MD Bureau1 Jan 2021 5:15 PM ISTA posthoc analysis on SUSTAIN 6 and PIONEER 6 trial showed semaglutide was associated with consistent reduction in major Adverse cardiovascular event...
Long-term weight control improves blood sugar levels in diabetes, finds Study Dr Kartikeya Kohli31 Dec 2020 11:45 AM ISTDecreased beta-cell function is principally responsible for the loss of blood sugar control and largely explains the difficulty of maintaining target...
FIRST: Glenmark launches Remogliflozin, Vildagliptin FDC drug priced at Rs 14 per tablet to treat diabetes in India Ruchika Sharma30 Dec 2020 1:03 PM ISTMumbai: Drugmaker, Glenmark Pharmaceuticals Limited, has launched a fixed dose combination (FDC) of its novel, patent protected and globally ...
Sitagliptin may not control blood sugar during bypass surgery in diabetics: Study Medha Baranwal30 Dec 2020 11:30 AM ISTUSA: Perioperative administration of sitagliptin in diabetes patients undergoing bypass surgery does not prevent hyperglycemia or complications, finds...
SGLT2 inhibitors may trigger rare complications for COVID-19 patients Hina Zahid30 Dec 2020 11:15 AM ISTDiabetes is a known risk factor for morbidity and mortality related to COVID-19. In diabetes patients, rare but severe complications, like the...
Periconception blood sugar control improves maternal and perinatal outcomes: JAMA Medha Baranwal28 Dec 2020 4:00 PM ISTCanada: Reduction in blood sugar levels improves outcomes for mother and child in women having diabetes before pregnancy, suggests a recent study in...
Blood sugar targets- ADA's Standards of Medical Care in Diabetes 2021 Medha Baranwal28 Dec 2020 12:45 PM ISTThe American Diabetes Association (ADA) has released "Standards of Medical Care in Diabetes" which includes the ADA's current clinical practice...
DPP-4 inhibitors and SGLT2 inhibitors effective in diabetics after kidney transplant Medha Baranwal26 Dec 2020 12:30 PM ISTGreece:Evidence regarding the utilization of DPP-4 inhibitors and particularly SGLT2 inhibitors and GLP-1 receptor agonists is limited in renal...
